Last updated on November 2017

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor


Brief description of study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Detailed Study Description

This is a 6 month study examining the safety and efficacy of an investigational medication in subjects with active psoriatic arthritis who have previously had an inadequate response to at least one TNF inhibitor either due to lack of efficacy or an adverse event.

Clinical Study Identifier: TX5279

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jacob Aelion

West Tennessee Research Institute
Jackson, TN USA
  Connect »

Herbert Baraf

The Center For Rheumatology And Bone Research
Wheaton, MD USA
  Connect »

Charles Birbara

Clinical Pharmacology Study Group
Worcester, MA USA
  Connect »

Melvin Churchill

Physician Research Collaboration, LLC
Lincoln, NE USA
  Connect »

Asif Cochinwala

Pioneer Research Solutions, Inc.
Houston, TX USA
  Connect »

Pamela Freeman

Rheumatology Associates of Central Florida, PA
Orlando, FL USA
  Connect »

Geoffrey Gladstein

New England Research Associates, LLC
Trumbull, CT USA
  Connect »

Michael Kohen

Millennium Research
Ormond Beach, FL USA
  Connect »

Tatiana Nagibina

Arthritis Center, Inc.
Palm Harbor, FL USA
  Connect »

Michael Luggen

Cincinnati Rheumatic Disease Study Group, Inc.
Cincinnati, OH USA
  Connect »

John Tesser

Arizona Arthritis & Rheumatology Research, PLLC
Glendale, AZ USA
  Connect »

John Budd

Clayton Medical Research
St. Louis, MO USA
  Connect »

Mark Genovese

Stanford University School of Medicine
Palo Alto, CA USA
  Connect »

Alice Gottleib

Tufts Medical Center
Boston, MA USA
  Connect »

Charles Ludivico

East Penn Rheumatology Associates, P.C.
Bethlehem, PA USA
  Connect »

Philip Mease

Seattle Rheumatology Associates
Seattle, WA USA
  Connect »

Joseph Merola

Brigham & Women's Hospital
Boston, MA USA
  Connect »

David Ridley

St. Paul Rheumatology, PA
Eagan, MN USA
  Connect »

Guillermo Valenzuela

Integral Rheumatology & Immunology Specialists (IRIS)
Plantation, FL USA
  Connect »